Patent · US Active

Antibodies with low immunogenicity and uses thereof

US11427632B2 · kind B2 · utility

0Cited by

11References

15Claims

0Family size

Assignee

CELGENE CORPORATION · US

Inventors

Jeffrey C. Johnson · Flemington, US
Lawrence Dearth · Encinitas, US
Haralambos HADJIVASSILIOU · San Diego, US
Jeonghoon Sun · Thousand Oaks, US
Kandasamy Hariharan · San Diego, US

Key dates

Filing date	Jul 5, 2017
Grant date	Aug 30, 2022
Priority date	—
Expiry date	Jul 16, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided herein are antibodies and antigen-binding fragments thereof with low or no immunogenicity in humans and optionally with desirable manufacturing properties. Also provided are compositions comprising such antibodies or antigen-binding fragments, methods of using such antibodies, and methods for making such antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.